Tim Xiao, CFA, FRM, is an accomplished finance professional currently serving as the Chief Financial Officer and Board Member of Eccogene since December 2020. Tim has been a Partner at Delos Capital since December 2014, concentrating on investments in disruptive life sciences companies across the US and Asia Pacific. In addition to these roles, Tim holds positions as Principal and Vice President at STRM.BIO and has various board memberships and observer roles in companies such as Sirius Therapeutics, Rgenta Therapeutics Inc., ReNiva Inc., Curatia Medical, Allecra Therapeutics, and Zenas BioPharma. Tim also served as Chief Executive Officer of Odeon Therapeutics from March 2022 to May 2024. Tim's academic background includes a Master of Science in Biotechnology from The Johns Hopkins University and a Bachelor of Science in International Economics & Trade from Shanghai Jiao Tong University, supplemented by an exchange program at The University of British Columbia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices